3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
6
Peritoneal Neoplasms
6
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Colorectal Neoplasms
3
Pancreatic Neoplasms
2
Neoplasms
2
Gastric Adenocarcinoma
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Appendiceal Neoplasms
2
Uterine Neoplasms
1
Stomach Diseases
1
Pseudomyxoma Peritonei
1
Ovarian Epithelial Cancer Recurrent
1
Locally Advanced Gastric Cancer
1
Krukenberg Tumor
1
HIPEC
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Gastric Cancer Peritoneal Metastases
1
Digestive System Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Interventions
Cisplatin
15
Pemetrexed
12
pembrolizumab
9
Carboplatin
8
Nivolumab
7
Cyclophosphamide
6
Platinum
5
Ipilimumab
5
1,2-diaminocyclohexaneplatinum II citrate
5
fludarabine
3
Radiotherapy, Intensity-Modulated
3
Interleukin-2
3
Gemcitabine
3
tremelimumab
2
durvalumab
2
atezolizumab
2
aldesleukin
2
Radiotherapy
2
Radiation
2
Photochemotherapy
2
Pharmaceutical Preparations
2
Methotrexate
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
Cerebral Decortication
2
nintedanib
1
methoxyamine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
cediranib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Hyperthermic Intraperitoneal Chemotherapy
×
1 year
×
Clear all
No trials found.